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Abstract
In this article the investigation of heparin binding capac-
ity of three biocompatible polyurethane coating are shown.
The polyurethanes as coating on metal carrier were studied.
The heparin binding capacity has measured by Optical Waveg-
uide Lightmode Spectroscopy (OWLS) that measure the heparin
elution.I have studied which type of polyurethane coated the
most heparin. The heparin binding capacity was compared of
smooth, porous-free, and porous coating. The porous coating
had higher heparin binding capacity than the smooth coating.
Furthermore it was studied, if the heparin soaking time is in-
creased in case of the porous coating, the heparin absorption is
increased too. It was also concluded, that the increase of the
time of the heparin soaking cause increase of heparin absorp-
tion.
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1 Introduction
In the treatment of coronary diseases only the surgical inter-
vention were considered to the 90s, but now the percutaneous ra-
diological interventions have been widespread, sparing patients
from a long convalescence time and complications after car-
diac surgery [1]. In the 1990s the stents have been developed,
which can open the narrowed blood vessels, and can prevent its
restenosis [1, 2]. After stent implantation neointima hyperpla-
sia and restenosis frequently has occurred [3]. The first drug-
eluting stents were appeared in 2002, altering the modern cardi-
ology. The first generation of drug-eluting stents has increased
the incidence of thrombosis after implantation, but the studies
in 2006-2007 have shown that this occurrence is very limited
[2]. The drug-eluting stents reduce the incidence of restenosis
[3].Different methods exist to fix the drug to the stent: drug on
bare metal, drug mixed with coating, special slot with drug, drug
loaded in stent reservoirs [4].
As far back as 1990s it is discovered that the polymer-coated
stents and blood vessels can reduce the interaction of damaged
vessel area and blood components. 1992 onwards binding to
metal and slow release are developed in case of heparin-coated
stents [5–8]. The current researches deal with the development
of biodegradable polymer coatings [9, 10]. In some studies
sheets were used instead of stents on account of hardly han-
dling of stents too.The material of the sheets was same as stents,
316LVM austenitic stainless steel [11, 12]. The Department of
Materials Science and Engineering of BME, the Minvasive Ltd.
and the Research Group for Metals Technology of HAS and
BME work together on the development of stents for 15 years
[13]. This group started the development of drug-eluting stents.
One of the initial steps of this research is presented in this arti-
cle.
2 Materials and methods
2.1 Samples
Sheets were used for these experiments instead of stents on
account of hardly handling of stents. The sheets were 12×3
mm, 316LVM austenitic stainless steel. Cutting burr was on the
surface of the sheets because of the laser cutting. These burr dis-
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appeared after etching. The etching taken 5 minutes to the burr
certainly disappeared. Etching liquor and ultrasonic purification
machine were used to the etching of sheets.After etching, the
samples were cleaned with high purity ethanol through which
dries quickly and spotless. After drying the samples were elec-
tropolished one at the time to resulted in a smooth surface where
the edges became round. Electropolishing stents, given the pa-
rameters of the recommendations are based on the size of the
surface is applied on the sheets. The optimized parameters for
electropolishing were 0,01 A/mm2 and 90 seconds.
2.2 Coating preparation
The coatings were prepared from three, commercially avail-
able biocompatible polyurethane from 2 wt% solution by dip-
ping technique. Three layers were made, and two types of
coatings were prepared: smooth, porous-free, and porous. The
smooth coatings were prepared at room temperature, the solu-
tion were not mixed, slow drying was applied, while the porous
coatings were prepared from 4 oC solution, and were dried in
laminar flow.
2.3 Heparin binding
The coated sheets were soaked during 24 or 48 hour in 1 mM
heparin solution, the control samples were soaked in 10 mM
Hepes-1 buffer. After this, the sheets were incubated alone in
420 µl 10 mM Hepes-1 buffer for 15, or 120 minutes, or 24
hours. Three samples were made of each type to perform three
parallel measurements.
2.4 Dissolution testing
The eluting heparin was measured by Optical Waveguide
Lightmode Spectroscopy (OWLS).The OWLS technique is
based on the measurement of the incident angle dependent pho-
tocurrent. A linearly polarized laser beam is incoupled into the
waveguiding layer due to a surface grating of the sensor chip.
The angle dependence of the photocurrent shows sharp peaks
for both the magnetic and electric modes of the light at the right
incoupling angles. The position of these peaks depends on the
effective refractive index. Changes in refractive index caused
by the adsorbed or any covering medium change the position of
these peaks [14]. The Fig. 1 indicates ray-optic representation
of a coupled and guided wave through waveguide layer of the
sensor chip. That is, He–Ne laser (k = 632.8 nm) is diffracted
by a grating at the interface and starts to propagate via the to-
tal internal reflection inside waveguide layer. At a well-defined
incident angle (α), the phase shift during one internal reflection
equals zero (constructive interference) and a guided mode is ex-
cited, which generates an evanescent field penetrating into cov-
ering medium [15]. The change in refractive index at the surface
can be monitored on-line by precise measurement of incoupling
angle.
Fig. 1. Ray-optic representation of coupled and guided wave indicated by
arrows inside optical grating coupler sensor chip [15].
3 Results
Each sheet with heparin gave higher value than the control
which was soaked in buffer instead of heparin Fig. 2, Fig. 3.
The increase of the incubation time caused the increase of the
means of heparin elution. The sample 1 gave the lowest values,
and the sample 2 gave the highest values except for the 120 min-
utes incubation time from the smooth coating sheets with hep-
arin Fig. 2, Fig. 3.The sample 1 gave the lowest values, and the
sample 2 gave the highest values for all three incubation times
from the porous coating sheet with heparin Fig. 3.
Fig. 2. Means of heparin elution of smooth coated sheets
Fig. 3. Means of heparin elution of porous coated sheet
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Compared to the heparin elution of smooth and porous coat-
ing, we can see that the values of the porous coating sheets are
higher than the values of the smooth coating for each type of
polyurethane coatings Fig. 4. The increase of the incubation
time caused the increase of the means of heparin elution in case
of porous coating sheets with 48 hours soaked time too Fig. 5.
The sample 2 gave the highest values between the samples with
48 hours incubation time. Each sheet with 48 hours incubation
time gave highest values than sheets with 24 hours incubation
time except the sample Fig. 3.
Fig. 4. Means of heparin elution of smooth and porous coating sheets soaked
in heparin
Fig. 5. Means of heparin elution of porous coating sheets soaked 24 or 48
hours in heparin
4 Discussion
All of the used polyurethane bound heparin. The sample
2 eluted the most heparin at the smooth and the porous coat-
ing sheets too.Compared to the smooth and porous coating, the
porous coating eluted more heparin than the smooth coating.The
binding surface is increased by pores, so the porous coating can
bind more heparin. If the coating sheets were soaked more time,
in this case 48 hours instead of 24 hours, then the heparin elution
of sheets were increased. The 48 hours were selected to make
sure increase the heparin elution. The coated sheet is soaked on
and on in heparin, it is bind more heparin, so it can elute more
heparin during the elution measure.
5 Conclusions
The used polyurethane coatings are suitable for development
active coatings, because it was appropriate for heparin bind-
ing and elution too. The heparin elution may be increased
by application of porous coating or increased of soaked time
in heparin.The amount of heparin binding and elution can
be controlled by the different surface, and different types of
polyurethane coatings.
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